Position in TMO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$29,863,508
+$8,470,157 QoQ
Shares Held
59,565
+36.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#378
of 2,606 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $1,383,676,421 across 25 Diagnostics & Research names. TMO ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
2,079,578 | $276,230,345 | |
| 2 | ILMN |
Illumina, Inc.
|
907,489 | $159,563,790 | |
| 3 | NEO |
Neogenomics Inc
|
10,113,261 | $147,552,477 | |
| 4 | VCYT |
Veracyte, Inc.
|
2,507,902 | $147,289,084 | |
| 5 | NTRA |
Natera, Inc.
|
511,214 | $138,769,040 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
202,754 | $106,737,815 | |
| 7 | WAT |
Waters Corp /De/
|
272,470 | $102,187,148 | |
| 8 | DGX |
Quest Diagnostics Inc
|
290,970 | $61,671,091 |
All Filings in TMO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,863,508 | 59,565 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $21,393,351 | 43,524 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $40,620,603 | 70,102 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $31,359,938 | 64,657 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $16,953,498 | 41,813 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $25,095,460 | 50,433 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $19,041,458 | 36,602 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $19,277,115 | 31,164 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $13,623,708 | 24,636 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $21,408,289 | 36,834 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $13,487,904 | 25,411 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $13,266,209 | 26,209 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $24,181,025 | 46,346 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,752,199 | 34,270 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $207,318,814 | 376,471 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $33,687,559 | 66,420 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $201,150,506 | 370,252 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $233,780,451 | 395,802 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $69,868,702 | 104,713 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $51,219,734 | 89,650 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $237,068,872 | 519,455 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $131,271,243 | 281,831 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $119,455,443 | 270,555 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $101,045,031 | 278,868 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $101,096,877 | 356,477 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||